Standard BioTools - 15 Year Stock Price History | LAB
Historical daily share price chart and data for Standard BioTools since 2011 adjusted for splits and dividends. The latest closing stock price for Standard BioTools as of September 15, 2026 is 0.69.
- The all-time high Standard BioTools stock closing price was 48.89 on March 05, 2014.
- The Standard BioTools 52-week high stock price is 1.72, which is 149.3% above the current share price.
- The Standard BioTools 52-week low stock price is 0.63, which is 8.7% below the current share price.
- The average Standard BioTools stock price for the last 52 weeks is 1.09.
| Standard BioTools Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 0.9857 | 1.2700 | 1.6400 | 0.6400 | 0.6903 | -46.07% |
| 2025 | 1.2910 | 1.7500 | 2.0600 | 0.9216 | 1.2800 | -26.86% |
| 2024 | 2.1658 | 2.2200 | 2.9200 | 1.4200 | 1.7500 | -20.81% |
| 2023 | 2.1764 | 1.3000 | 3.0500 | 1.3000 | 2.2100 | 88.89% |
| 2022 | 2.1587 | 3.7200 | 3.9900 | 0.9300 | 1.1700 | -70.15% |
| 2021 | 5.5256 | 6.1700 | 7.4100 | 3.6300 | 3.9200 | -34.67% |
| 2020 | 5.0807 | 3.4900 | 11.4300 | 1.2400 | 6.0000 | 72.41% |
| 2019 | 8.6295 | 8.5900 | 14.3600 | 2.3000 | 3.4800 | -59.63% |
| 2018 | 6.7886 | 6.2300 | 8.8300 | 4.8600 | 8.6200 | 46.35% |
| 2017 | 5.1843 | 7.5900 | 8.3300 | 2.7100 | 5.8900 | -19.09% |
| 2016 | 8.0352 | 10.1200 | 10.9100 | 4.3400 | 7.2800 | -32.65% |
| 2015 | 23.9509 | 33.6100 | 45.5400 | 7.3800 | 10.8100 | -67.95% |
| 2014 | 32.9927 | 36.8000 | 48.8900 | 22.0600 | 33.7300 | -11.89% |
| 2013 | 20.9563 | 14.5000 | 39.3700 | 14.2700 | 38.2800 | 167.51% |
| 2012 | 14.7265 | 13.3200 | 17.1500 | 12.6000 | 14.3100 | 8.74% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.273B | $0.085B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |